Stem Cell Population Expansion Technologies and Stem Cell Therapy
Gamida Cell has raised €76M across 7 funding rounds from 2 investors, most recently a Growth/Late round in Oct 2015. Based in Jerusalem, Israel; founded 1998; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2015-10-01 | Growth/Late | €13M | — | View deal → |
| 2014-08-01 | Growth/Late | €26M | — | View deal → |
| 2014-01-01 | Growth/Late | €3.0M | — | View deal → |
| 2012-05-01 | Series D+ | €7.6M | Amgen,Auriga Partners | View deal → |
| 2006-09-01 | Series D+ | €12M | — | View deal → |
| 2005-08-01 | Series C | €3.0M | Auriga Partners | View deal → |
| 2001-10-01 | Series B | €11M | Auriga Partners | View deal → |
